206 related articles for article (PubMed ID: 24403505)
1. Neuronal drug transporters in platinum drugs-induced peripheral neurotoxicity.
Cavaletti G; Ceresa C; Nicolini G; Marmiroli P
Anticancer Res; 2014 Jan; 34(1):483-6. PubMed ID: 24403505
[TBL] [Abstract][Full Text] [Related]
2. The role of oxidative stress and anti-oxidant treatment in platinum-induced peripheral neurotoxicity.
Carozzi VA; Marmiroli P; Cavaletti G
Curr Cancer Drug Targets; 2010 Nov; 10(7):670-82. PubMed ID: 20578989
[TBL] [Abstract][Full Text] [Related]
3. Role of platinum DNA damage-induced transcriptional inhibition in chemotherapy-induced neuronal atrophy and peripheral neurotoxicity.
Yan F; Liu JJ; Ip V; Jamieson SM; McKeage MJ
J Neurochem; 2015 Dec; 135(6):1099-112. PubMed ID: 26364854
[TBL] [Abstract][Full Text] [Related]
4. Neurotoxicity Associated with Platinum-Based Anti-Cancer Agents: What are the Implications of Copper Transporters?
Stojanovska V; McQuade R; Rybalka E; Nurgali K
Curr Med Chem; 2017; 24(15):1520-1536. PubMed ID: 28079002
[TBL] [Abstract][Full Text] [Related]
5. Drug transporters in chemotherapy induced peripheral neurotoxicity: current knowledge and clinical implications.
Ceresa C; Cavaletti G
Curr Med Chem; 2011; 18(3):329-41. PubMed ID: 21143122
[TBL] [Abstract][Full Text] [Related]
6. Neuronal expression of copper transporter 1 in rat dorsal root ganglia: association with platinum neurotoxicity.
Liu JJ; Jamieson SM; Subramaniam J; Ip V; Jong NN; Mercer JF; McKeage MJ
Cancer Chemother Pharmacol; 2009 Sep; 64(4):847-56. PubMed ID: 19466412
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.
Argyriou AA; Bruna J; Marmiroli P; Cavaletti G
Crit Rev Oncol Hematol; 2012 Apr; 82(1):51-77. PubMed ID: 21908200
[TBL] [Abstract][Full Text] [Related]
8. Contributions of rat Ctr1 to the uptake and toxicity of copper and platinum anticancer drugs in dorsal root ganglion neurons.
Liu JJ; Kim Y; Yan F; Ding Q; Ip V; Jong NN; Mercer JF; McKeage MJ
Biochem Pharmacol; 2013 Jan; 85(2):207-15. PubMed ID: 23123662
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin-induced neuropathy: a tale of two electrolytes.
Babiker HM; Green MR; Nelson MA; Elquza E
Support Care Cancer; 2015 Jun; 23(6):1483-5. PubMed ID: 25801447
[No Abstract] [Full Text] [Related]
10. Membrane transporters as mediators of cisplatin side-effects.
Ciarimboli G
Anticancer Res; 2014 Jan; 34(1):547-50. PubMed ID: 24403515
[TBL] [Abstract][Full Text] [Related]
11. Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs.
Screnci D; McKeage MJ; Galettis P; Hambley TW; Palmer BD; Baguley BC
Br J Cancer; 2000 Feb; 82(4):966-72. PubMed ID: 10732773
[TBL] [Abstract][Full Text] [Related]
12. Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approaches.
Screnci D; McKeage MJ
J Inorg Biochem; 1999 Oct; 77(1-2):105-10. PubMed ID: 10626361
[TBL] [Abstract][Full Text] [Related]
13. Platinum accumulation in oxaliplatin-induced peripheral neuropathy.
Wei G; Gu Z; Gu J; Yu J; Huang X; Qin F; Li L; Ding R; Huo J
J Peripher Nerv Syst; 2021 Mar; 26(1):35-42. PubMed ID: 33462873
[TBL] [Abstract][Full Text] [Related]
14. Platinum-induced neurotoxicity and preventive strategies: past, present, and future.
Avan A; Postma TJ; Ceresa C; Avan A; Cavaletti G; Giovannetti E; Peters GJ
Oncologist; 2015 Apr; 20(4):411-32. PubMed ID: 25765877
[TBL] [Abstract][Full Text] [Related]
15. Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer.
Lersch C; Schmelz R; Eckel F; Erdmann J; Mayr M; Schulte-Frohlinde E; Quasthoff S; Grosskreutz J; Adelsberger H
Clin Colorectal Cancer; 2002 May; 2(1):54-8. PubMed ID: 12453338
[TBL] [Abstract][Full Text] [Related]
16. Drug transporters of platinum-based anticancer agents and their clinical significance.
Burger H; Loos WJ; Eechoute K; Verweij J; Mathijssen RH; Wiemer EA
Drug Resist Updat; 2011 Feb; 14(1):22-34. PubMed ID: 21251871
[TBL] [Abstract][Full Text] [Related]
17. The fundamental role of morphology in experimental neurotoxicology: the example of chemotherapy-induced peripheral neurotoxicity.
Marmiroli P; Nicolini G; Miloso M; Scuteri A; Cavaletti G
Ital J Anat Embryol; 2012; 117(2):75-97. PubMed ID: 23420996
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
[TBL] [Abstract][Full Text] [Related]
19. Platinum-based chemotherapy: gastrointestinal immunomodulation and enteric nervous system toxicity.
Stojanovska V; Sakkal S; Nurgali K
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G223-32. PubMed ID: 25501548
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of oxaliplatin neurotoxicity by drugs in humans and experimental animals: a minireview of recent literature.
Ali BH
Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):272-9. PubMed ID: 20050845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]